Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

7VKM

Crystal structure of TrkA (G595R) kinase domain

Summary for 7VKM
Entry DOI10.2210/pdb7vkm/pdb
DescriptorTyrosine-protein kinase receptor (2 entities in total)
Functional Keywordstrk, ntrk, macrocyclic inhibitor, drug resistance, repotrectinib, transferase
Biological sourceHomo sapiens (Human)
Total number of polymer chains1
Total formula weight37335.92
Authors
Murray, B.W.,Rogers, E.,Zhai, D.,Deng, W.,Chen, X.,Sprengeler, P.A.,Zhang, X.,Graber, A.,Reich, S.H.,Stopatschinskaja, S.,Solomon, B.,Besse, B.,Drilon, A. (deposition date: 2021-09-30, release date: 2021-10-13, Last modification date: 2023-11-29)
Primary citationMurray, B.W.,Rogers, E.,Zhai, D.,Deng, W.,Chen, X.,Sprengeler, P.A.,Zhang, X.,Graber, A.,Reich, S.H.,Stopatschinskaja, S.,Solomon, B.,Besse, B.,Drilon, A.
Molecular Characteristics of Repotrectinib That Enable Potent Inhibition of TRK Fusion Proteins and Resistant Mutations.
Mol.Cancer Ther., 20:2446-2456, 2021
Cited by
PubMed: 34625502
DOI: 10.1158/1535-7163.MCT-21-0632
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.55 Å)
Structure validation

219140

PDB entries from 2024-05-01

PDB statisticsPDBj update infoContact PDBjnumon